GEN
Get informed when a big investor buys or sells
+ FollowUndervalued by 59.4% based on the discounted cash flow analysis.
| Market cap | $15.54 Billion |
|---|---|
| Enterprise Value | $24.91 Billion |
| Dividend Yield | $0.50 (1.94%) |
| Earnings per Share | $1.59 |
| Beta | 1.09 |
| Outstanding Shares | 602,000,000 |
| P/E Ratio | 15.96 |
|---|---|
| PEG | 6.12 |
| Price to Sales | 3.31 |
| Price to Book Ratio | 6.63 |
| Enterprise Value to Revenue | 4.98 |
| Enterprise Value to EBIT | 16.83 |
| Enterprise Value to Net Income | 25 |
| Total Debt to Enterprise | 0.39 |
| Debt to Equity | 3.75 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.6248▼ 31.73% |
|---|---|
| Total Calls | 550,400▲ 14.34% |
| Total Puts | 343,900▼ 24.17% |
Holdings and activity of institutional investors.
| Ownership % | 85.43%▼ 1.02% |
|---|---|
| Total Invested | $9.91B▼ 31.64% |
| Investors Holding | 681▼ 19.00% |
No data
This committee controls taxation and entitlement spending, specifically impacting hospitals through Medicare and Medicaid pricing and overall tax policy. It is a primary regulatory and funding committee for the healthcare sector.
This committee directly allocates federal spending, including critical funds for Medicare, Medicaid, and other health programs, which are primary revenue sources for general medical and surgical hospitals.
This committee directly regulates labor laws, which are a major cost factor for hospitals, and has broad oversight of health policy that significantly impacts general medical and surgical hospitals.